Harr Steve
Insider CIK 1627387 · LOXO Director · JUNO See Remarks · SANA President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SANA Sana Biotechnology, Inc. | F Tax w/h | 2026-03-09 | 2026-03-10 | 12,819 | $3.10 | $39.7K | 7,944,251 | SEC↗ |
| SANA Sana Biotechnology, Inc. | F Tax w/h | 2026-03-09 | 2026-03-10 | 11,526 | $3.13 | $36.1K | 7,957,070 | SEC↗ |
| SANA Sana Biotechnology, Inc. | M Exercise deriv | 2026-03-07 | 2026-03-10 | 50,000 | — | $0 | 100,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | M Exercise | 2026-03-07 | 2026-03-10 | 50,000 | — | $0 | 7,968,596 | SEC↗ |
| SANA Sana Biotechnology, Inc. | M Exercise deriv | 2026-03-06 | 2026-03-10 | 41,666 | — | $0 | 125,001 | SEC↗ |
| SANA Sana Biotechnology, Inc. | M Exercise | 2026-03-06 | 2026-03-10 | 41,666 | — | $0 | 7,918,596 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2026-03-05 | 2026-03-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2026-03-05 | 2026-03-06 | 900,000 | — | $0 | 900,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | F Tax w/h | 2025-03-10 | 2025-03-10 | 12,820 | $2.56 | $32.8K | 7,876,930 | SEC↗ |
| SANA Sana Biotechnology, Inc. | M Exercise deriv | 2025-03-07 | 2025-03-10 | 50,000 | — | $0 | 150,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | M Exercise | 2025-03-07 | 2025-03-10 | 50,000 | — | $0 | 7,889,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2025-03-06 | 2025-03-10 | 166,667 | — | $0 | 166,667 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2025-03-06 | 2025-03-10 | 750,000 | — | $0 | 750,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 900,000 | — | $0 | 900,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2023-03-02 | 2023-03-03 | 650,000 | — | $0 | 650,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2022-03-03 | 2022-03-08 | 760,000 | — | $0 | 760,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | G Gift | 2021-04-14 | 2022-04-15 | 167,000 | — | $0 | 7,839,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | G Gift | 2021-04-14 | 2022-04-15 | 167,000 | — | $0 | 8,006,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 156,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 800,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 1,075,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 2,031,250 | — | $0 | 8,173,750 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 11,000 | $235.00 | $2.58M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 8,750 | $235.00 | $2.06M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 15,625 | $235.00 | $3.67M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2018-06-13 | 2018-06-14 | 8,750 | — | $0 | 8,750 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 155,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 85,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 98,750 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 127,841 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 11,544 | — | $0 | 35,893 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 29,135 | — | $0 | 47,437 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | U Tender | 2018-03-05 | 2018-03-07 | 492,355 | $87.00 | $42.83M | 147,162 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 50,010 | $87.00 | $4.35M | 97,152 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 20,580 | — | $0 | 76,572 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 35,893 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2018-02-27 | 2018-03-01 | 11,544 | — | $0 | 639,517 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | G Gift | 2018-02-07 | 2018-02-09 | 162,790 | — | $0 | 627,973 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | F Tax w/h | 2018-02-07 | 2018-02-09 | 1,704 | $85.49 | $145.7K | 790,763 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2018-01-31 | 2018-02-02 | 29,135 | — | $0 | 792,467 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2017-12-21 | 2017-12-22 | 8,750 | — | $0 | 98,750 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2017-12-21 | 2017-12-22 | 8,750 | $8.72 | $76.3K | 772,082 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-12-21 | 2017-12-22 | 500 | $45.18 | $22.6K | 763,332 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-12-21 | 2017-12-22 | 8,250 | $44.74 | $369.1K | 763,832 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-10-20 | 2017-10-20 | 35,893 | — | $0 | 763,332 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2017-07-03 | 2017-07-05 | 8,750 | — | $0 | 107,500 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-07-03 | 2017-07-05 | 8,750 | $30.00 | $262.5K | 727,439 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2017-07-03 | 2017-07-05 | 8,750 | $8.72 | $76.3K | 736,189 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2017-06-27 | 2017-06-29 | 8,750 | — | $0 | 116,250 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2017-06-27 | 2017-06-29 | 8,750 | $8.72 | $76.3K | 736,189 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-06-27 | 2017-06-29 | 8,750 | $30.00 | $262.5K | 727,439 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2017-02-07 | 2017-02-09 | 127,841 | — | $0 | 127,841 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-02-07 | 2017-02-09 | 27,439 | — | $0 | 727,439 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2016-11-07 | 2016-11-09 | 15,625 | — | $0 | 15,625 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-06-10 | 2016-06-13 | 16,052 | $43.69 | $701.3K | 700,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-06-10 | 2016-06-13 | 13,948 | $42.89 | $598.2K | 716,052 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-04 | 2016-03-04 | 5,000 | $45.00 | $225.0K | 730,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-01 | 2016-03-02 | 2,013 | $35.06 | $70.6K | 762,987 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-01 | 2016-03-02 | 10,581 | $36.20 | $383.0K | 752,406 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-01 | 2016-03-02 | 900 | $36.82 | $33.1K | 751,506 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-01 | 2016-03-02 | 6,387 | $38.18 | $243.9K | 745,119 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-01 | 2016-03-02 | 10,076 | $39.21 | $395.1K | 735,043 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-01 | 2016-03-02 | 43 | $39.88 | $1.7K | 735,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2016-02-02 | 2016-02-04 | 155,000 | — | $0 | 155,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-12-10 | 2015-12-11 | 3,600 | $46.90 | $168.8K | 765,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-12-10 | 2015-12-11 | 31,400 | $46.38 | $1.46M | 768,600 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2015-03-03 | 2015-03-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2015-03-03 | 2015-03-26 | 85,000 | — | $0 | 85,000 | SEC↗ |